Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Director Shareholding

29 Mar 2005 10:20

Tissue Science Laboratories PLC29 March 2005 Tissue Science Laboratories PLC29 March 2005 Tissue Science Laboratories plc (the "Company") Director Shareholding Further to the Result of Placing and Open Offer announcement released on Friday18 March 2005, of the 1,472,815 Offer Shares allotted under the Open Offer: 1190 ordinary shares were allotted to Mr Martin Hunt, the Chief ExecutiveOfficer of the Company, at a price of 171p per share. As a result of thisallotment, Mr Hunt currently has a beneficial interest in 7,440 ordinary sharesof 10p each in the Company representing 0.025% per cent of the enlarged issuedshare capital; and 761 ordinary shares were allotted to Mr David Jennings, the Finance Director ofthe Company, at a price of 171p per share. As a result of this allotment, MrJennings currently has a beneficial interest in 4,761 ordinary shares of 10peach in the Company representing 0.016% per cent of the enlarged issued sharecapital. END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Nov 20202:57 pmRNSResults of Annual General Meeting
11th Nov 20207:00 amRNS2020 AGM Statement and Business Update
10th Nov 202011:05 amRNSSecond Price Monitoring Extn
10th Nov 202011:00 amRNSPrice Monitoring Extension
5th Nov 202012:10 pmRNS2020 Annual General Meeting to be virtual only
28th Oct 20201:16 pmRNSHolding(s) in Company
26th Oct 20202:06 pmRNSSecond Price Monitoring Extn
26th Oct 20202:01 pmRNSPrice Monitoring Extension
26th Oct 20209:00 amRNSPrice Monitoring Extension
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:36 pmRNSPrice Monitoring Extension
15th Oct 202011:00 amRNSCapital Return and Dividend and Notice of AGM
21st Sep 202011:05 amRNSSecond Price Monitoring Extn
21st Sep 202011:00 amRNSPrice Monitoring Extension
17th Sep 20204:36 pmRNSPrice Monitoring Extension
17th Sep 20202:05 pmRNSSecond Price Monitoring Extn
17th Sep 20202:00 pmRNSPrice Monitoring Extension
17th Sep 20207:00 amRNSResults for the year ended 30 June 2020
4th Sep 20201:05 pmRNSNotice of Final Results
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
14th Aug 20204:41 pmRNSSecond Price Monitoring Extn
14th Aug 20204:36 pmRNSPrice Monitoring Extension
12th Aug 20203:02 pmRNSHolding(s) in Company
12th Aug 202012:06 pmRNSHolding(s) in Company
10th Aug 20202:06 pmRNSSecond Price Monitoring Extn
10th Aug 20202:01 pmRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSSettlement of legal proceedings
6th Jul 202010:00 amRNSDirector/PDMR Shareholding
1st Jul 202011:40 amRNSHolding(s) in Company
29th Jun 202011:40 amRNSPDMR Shareholding Notification
29th Jun 20207:00 amRNSPDMR Shareholding Notification
23rd Jun 20201:20 pmRNSHolding(s) in Company
23rd Jun 202010:22 amRNSClearpay Trading Update
22nd Jun 202010:20 amRNSHolding(s) in Company
19th Jun 202010:15 amRNSHolding(s) in Company
17th Jun 202010:06 amRNSHolding(s) in Company
17th Jun 202010:05 amRNSHolding(s) in Company
14th May 202011:25 amRNSHolding(s) in Company
13th May 202012:09 pmRNSHolding(s) in Company
13th May 20209:50 amRNSDirector/PDMR Shareholding
12th May 202011:06 amRNSSecond Price Monitoring Extn
12th May 202011:00 amRNSPrice Monitoring Extension
11th May 20209:40 amRNSBoard Change
7th May 20209:30 amRNSDirector/PDMR Shareholding
5th May 202011:05 amRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNSInterim Results for 6 month ended 31 Dec 2019
2nd Dec 20192:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20192:00 pmRNSPrice Monitoring Extension
29th Nov 201911:50 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.